Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: No Antimicrobial Prophylaxis for Laparoscopic Distal Gastrectomy [Phase 2]
A Phase 2 clinical trial evaluates whether antimicrobial prophylaxis can be omitted during laparoscopic distal gastrectomy for gastric cance…
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma [Phase 2]
Phase 2 trial assessing preoperative chemotherapy with bevacizumab and PET-guided salvage therapy in locally advanced but resectable gastric…
-
CLINICAL_TRIALS research · 2016-02-03Clinical Trial Update: Novel Endoscopic Imaging Methods for the Evaluation of Blood Vessels in Gastrointestinal Cancers [NA]
This entry reports an update on a clinical trial evaluating novel endoscopic imaging methods to evaluate blood vessels in gastric and colore…
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Compliance to ERAS After Gastric Surgery [Phase 2]
Phase 2 clinical trial completed; reports on adherence to Enhanced Recovery After Surgery (ERAS) protocols following gastric surgery for sto…
-
CLINICAL_TRIALS research · 2016-01-29Clinical Trial Update: An Open Label, Prospective, Multicentre, Non-interventional Study of Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer
Open-label, prospective, multicentre, non-interventional study of apatinib for chemotherapy-refractory advanced/metastatic gastric cancer; s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Irinotecan as 3rd Line Therapy in Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating irinotecan as third-line therapy for gastric cancer, with the trial status currently unknown.
-
CLINICAL_TRIALS research · 2016-01-26Clinical Trial Update: Serological Screening of Gastric Cancer in Wuxi Region [NA]
Clinical trial update on serological screening for gastric cancer in the Wuxi region, sponsored by Wuxi People's Hospital; status is unknown…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]
A Phase 2 clinical trial evaluated chemotherapy with or without vismodegib in patients with advanced stomach or gastroesophageal junction ad…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System [Phase 1]
Phase 1 clinical trial evaluating a HER2-positive T cell–mediated adaptive therapy for digestive-system cancers, including esophageal, gastr…
-
CLINICAL_TRIALS trial_result · 2016-01-15Clinical Trial Update: Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus [Phase 1]
Phase 1 study of selinexor in combination with irinotecan for gastric and distal esophageal adenocarcinoma was terminated.
-
CLINICAL_TRIALS trial_result · 2016-01-07Clinical Trial Update: A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection. [Phase 3]
This document reports on a randomized Phase III trial evaluating adjuvant chemotherapy with or without chemoradiotherapy after D2 gastrectom…
-
CLINICAL_TRIALS research · 2016-01-01Clinical Trial Update: Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver Metastasis [Phase 1, Phase 2]
This entry reports a Phase 1/2 clinical trial evaluating PIK-HER2 cell immunotherapy for advanced gastric cancer with liver metastasis, led …
-
CLINICAL_TRIALS research · 2015-12-29Clinical Trial Update: Novel Esophago-Jejunal Anastomosis Method During Totally Laparoscopic Total Gastrectomy [NA]
Completed clinical trial update on a novel esophago-jejunal anastomosis method used in totally laparoscopic total gastrectomy for gastric ca…
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: A Trial of RAD001/Capecitabine in Refractory Gastric Cancer [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the combination of everolimus (RAD001) and capecitabine in refractory/metastatic gastric cancer. The …
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients [Phase 2]
A Phase 2 trial evaluating adjuvant chemotherapy for high-risk gastric cancer patients has been reported; the current status of the study is…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric Cancer
A clinical trial is evaluating a Superior Mesenteric Vein lymphadenectomy for distal advanced gastric cancer, sponsored by Tianjin Medical U…
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer [Phase 2]
Phase 2 clinical trial comparing XELOX (capecitabine + oxaliplatin) versus S-1 with oxaliplatin and docetaxel as neoadjuvant chemotherapy fo…
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Proteiomic Fingerprints of Gastric Juice [NA]
This clinical trial update reports completed results from a study investigating proteomic fingerprints in gastric juice for gastric cancer.
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: A Comparison of XELOX Regimen and EOX Regimen as Neoadjuvant Chemotherapy Regimen for Locally Advanced Gastric Cancer.
This trial compared XELOX (capecitabine + oxaliplatin) versus EOX (epirubicin + oxaliplatin + capecitabine) as neoadjuvant chemotherapy for …
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of pemetrexed disodium and docetaxel in patients with advanced solid tumors has completed, studyi…
-
CLINICAL_TRIALS trial_result · 2015-11-30Clinical Trial Update: S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer [Phase 3]
This ClinicalTrials.gov entry documents a completed Phase 3 trial comparing S-1 plus cisplatin given every 3 weeks to S-1 plus oxaliplatin i…
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin [Phase 2]
This Phase 2 trial evaluated the combination of cetuximab, cisplatin, and irinotecan in patients with metastatic esophageal cancer, gastroes…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: PF-00299804 Monotherapy in Patients With HER-2 Positive Advance Gastric Cancer [Phase 2]
Phase 2 trial of PF-00299804 (neratinib) as monotherapy in HER2-positive advanced gastric cancer has completed enrollment and the study stat…
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy [Phase 2]
Phase 2 efficacy study results comparing ipilimumab to the standard of care after first-line chemotherapy in locally advanced unresectable o…
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer [Phase 2, Phase 3]
A clinical trial compares apatinib to docetaxel in patients with advanced gastric cancer, spanning Phase 2 and Phase 3.